ADARx Pharmaceuticals is a startup based in the United States, 3 tracked investors.
Based in the United States, ADARx Pharmaceuticals is a startup. Brouky records 3 investors associated with the company.
ADARx Pharmaceuticals is a clinical-stage biotechnology company developing RNA-based therapeutics using proprietary RNA science and targeted delivery platforms. Its pipeline includes multiple candidates (e.g., ADX-038/Agazisiran and others) targeting renal, hematologic, metabolic and neurodegenerative diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.